Image of the Month: Human intestinal enteroids
Human intestinal enteroids have revolutionized the study of gastrointestinal viruses like rotavirus.
Read More
Research
And now, your community health forecast…
In the not-so-distant future, people might be able to tune in to their favorite news source for an update on their community health status.
Read More
A new biomarker can better predict meningioma response to radiation
This new biomarker offers insights into how meningioma patients with different gene expression patterns respond differently to treatments
Read More
Rett patients receive a new gene therapy treatment at Texas Children’s Hospital and Baylor College of Medicine
Nearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read More
Human mini guts reveal new insights into Cronkhite-Canada syndrome and potential new therapies
The work also highlights the value of human organoid technology to improve the understanding of any disease and identify potential clinical applications.
Read More
Llama power: can tiny llama nanobodies improve norovirus anti-viral therapies?
Llama nanobodies may offer an option for treating norovirus, a global health problem for which there are no vaccines or antiviral drugs.
Read More
Team develops imaging method to capture previously inaccessible coordination of tiny hair-like cilia in live organisms
This new method gives researchers access to study previously inaccessible roles of cilia in the female reproductive system and infertility.
Read More
Image of the Month: Neural connections in the visual pathway of the brain
Like an elaborate superhighway, an intricate network of neuronal projections keeps neurons in the visual pathway connected.
Read More
Research connecting gut bacteria and oxytocin provides a new mechanism for microbiome-promoted health benefits
The details of how gut resident bacteria L. reuteri can affect the gut and other organs are beginning to fall into place.
Read More
eIF4A emerges as a potential Achilles’ heel for triple-negative breast cancer
Targeting eIF4A to interfere with the synthesis of proteins the cancer needs to grow is producing promising results.
Read More